• Citer

Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?

par Klastersky, Jean ;Awada, Ahmad ;Aoun, Michel ;Paesmans, Marianne
Référence Current opinion in oncology, 21, 4, page (297-302)
Publication Publié, 2009-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?
Auteur:	Klastersky, Jean; Awada, Ahmad; Aoun, Michel; Paesmans, Marianne
Informations sur la publication:	Current opinion in oncology, 21, 4, page (297-302)
Statut de publication:	Publié, 2009-07
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Chemotherapy-induced infection
	Febrile neutropenia
	Granulocyte colony-stimulating factors
	Prevention of infection
MeSH keywords:	Antineoplastic Agents -- adverse effects
	Antineoplastic Agents -- therapeutic use
	Fever -- etiology
	Fever -- prevention & control
	Granulocyte Colony-Stimulating Factor -- therapeutic use
	Humans
	Neoplasms -- drug therapy
	Neutropenia -- chemically induced
	Neutropenia -- prevention & control
	Risk Factors
Note générale:	Editorial
	Review
Langue:	Anglais
Identificateurs:	urn:issn:1040-8746
	info:doi/10.1097/CCO.0b013e32832c9651
	info:pii/00001622-200907000-00003
	info:scp/67650309542
	info:pmid/19509500